相关实验视频

Updated: May 29, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

通过直接作用抗病毒药物消除C型肝炎病毒后的长期肝脏发病率和死亡率

Eiichi Ogawa¹, Akira Kawano², Motoyuki Kohjima³

¹Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.

Journal of gastroenterology and hepatology

|February 3, 2025

概括

用DAA治疗C型肝炎显著改善了生存率. 在HCV消除后,轻度纤维化 (FIB-4 < 1.45) 的患者可能不再需要专业护理,而年龄较大的人在晚期纤维化患者中增加了HCC风险.

科学领域:

肝病学肝病学是一种肝病学.
病毒学病毒学
在瘤学瘤学.

背景情况:

准确的患者分层后肝炎C病毒 (HCV) 清除对于优化监测和治疗至关重要.
直接作用抗病毒药物 (DAA) 彻底改变了HCV治疗,导致治疗率高.

研究的目的:

通过DAA实现HCV治愈后,对患有肝细胞癌 (HCC) 风险的慢性型肝炎C患者进行分层.
确定影响de novo HCC发展和HCV消除后复发的关键因素.

主要方法:

一项多中心的,追溯的队列研究,对3024名慢性型肝炎的成年患者进行了DAA治疗.
对长期累积的新发性HCC发病率,HCC复发率和生存率的分析.
在没有肝硬化患者中,按年龄和FIB-4指数对HCC发展的分层.

主要成果:

在非肝硬化和FIB-4<1.45 (n=475) 的患者中,没有出现HCC.
高龄显著影响了非肝硬化和FIB-4≥3.25 (p=0.038) 的患者的HCC发病率.
代谢因素与HCC发病率无关;HCC复发通常发生在5年内,但HCV治愈改善了生存率.

结论:

年龄是HCV治愈后中度至晚期纤维化患者中新HCC发展的关键预测因素.
患有轻度纤维化 (FIB-4 < 1.45) 的患者可能是HCV消除后从专科护理出院的候选人.
消除HCV可以改善整体存活率,尽管有可能在5年内出现HCC复发.

关键词:

年龄的年龄年龄的年龄.直接作用的抗病毒药物.在C型肝炎病毒的感染中,肝细胞癌是肝细胞癌.死亡率死亡率复发性复发性复发性监控监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Drug Elimination: Non-Renal Routes

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...